BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie T, Wang ZG, Zhang JL, Liu H. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2012; 18(31): 4207-4214 [PMID: 22919255 DOI: 10.3748/wjg.v18.i31.4207] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Merchant N, Alam A, Bhaskar L. The correlation between hepatocellular carcinoma susceptibility and XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln – A meta-analysis. Human Gene 2023. [DOI: 10.1016/j.humgen.2023.201165] [Reference Citation Analysis]
2 Wang B, Xu Q, Yang HW, Sun LP, Yuan Y. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk. Oncotarget. 2016;7:20357-20367. [PMID: 26967386 DOI: 10.18632/oncotarget.7952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
3 Santonocito C, Scapaticci M, Nedovic B, Annicchiarico EB, Guarino D, Leoncini E, Boccia S, Gasbarrini A, Capoluongo E. XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population. Int J Biol Markers 2017;32:190-4. [DOI: 10.5301/jbm.5000241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
4 Qi Y, Cui L, Song Y, Li N. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Mol Biol Rep 2014;41:879-87. [PMID: 24390232 DOI: 10.1007/s11033-013-2929-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies. PLoS One. 2013;8:e78071. [PMID: 24205095 DOI: 10.1371/journal.pone.0078071] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
6 Mao D, Zhang Y, Lu H, Fu X. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk. Tumor Biol 2013;34:2529-38. [DOI: 10.1007/s13277-013-0760-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
7 Bao Y, Jiang L, Zhou JY, Zou JJ, Zheng JY, Chen XF, Liu ZM, Shi YQ. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies. PLoS One 2013;8:e64851. [PMID: 23717668 DOI: 10.1371/journal.pone.0064851] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
8 Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. PLoS One 2013;8:e55597. [PMID: 23383237 DOI: 10.1371/journal.pone.0055597] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]